Literature DB >> 34504686

Ehlers-Danlos syndrome kyphoscoliotic type 2 caused by mutations in the FKBP14 gene: an analysis of five cases.

Alla Nikolaevna Semyachkina1, Ekaterina Alexandrovna Nikolaeva1, Nailya Mansurovna Galeeva2, Alexander Vladimirovich Polyakov2, Maria Andreevna Kurnikova3, Vera Аlexandrovna Belova4, Irina Valerievna Shulyakova1, Ilya Sergeevich Dantsev1, Goar Vladimirovna Dzhivanshiryan1.   

Abstract

Background. This study deals with a rare (orphan) monogenic connective tissue disorder - Ehlers-Danlos syndrome kyphoscoliotic type 2 (EDSKS2). Kyphoscoliotic type 2 Ehlers-Danlos syndrome is an autosomal recessive disorder caused by mutations in the FKBP14 gene (7p14.3), which encodes the FKBP22 protein. According to the 2017 classification, this type is in group seven - collagen spatial structure and cross-linking defects. We present results of clinical examination and molecular genetic analysis for five patients with age varying from two to fifteen years.  Methods. Five patients were examined using clinical and laboratory methods. DNA samples used for the analysis were extracted from whole blood samples using a Wizard® Genomic DNA Purification Kit (Promega, USA) according to the manufacturer's protocol.  Results. The major clinical findings were kyphoscoliosis, early motor development delay, muscular weakness, hypotonia and hearing loss. Molecular genetic analysis detected a homozygous c.362dupC duplication in exon 3 of the FKBP14 gene in all five patients. This mutation is common in various countries. Differential diagnostics were carried out to exclude other Ehlers-Danlos syndrome types and myopathies.  Conclusions. Literature analysis and examination of five EDSKS2 patients demonstrated the involvement of major organs and systems, such as joints, spine, muscles, cardiovascular system, respiratory system, hearing, and vision, into the pathological process. Kidney mobility increases and nephroptosis seems to be secondary caused by muscular weakness. During molecular genetic analysis, to verify EDSKS2 it is recommended to initially search for the c.362dupC duplication, which appears to be common in European countries, including Russia. Copyright:
© 2021 Semyachkina AN et al.

Entities:  

Keywords:  FKBP14 gene; c.362dupC duplication; children; clinical findings; monogenic connective tissue disorders; rare (orphan) disorders

Mesh:

Substances:

Year:  2021        PMID: 34504686      PMCID: PMC8408539          DOI: 10.12688/f1000research.52268.1

Source DB:  PubMed          Journal:  F1000Res        ISSN: 2046-1402


  12 in total

1.  Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss.

Authors:  Matthias Baumann; Cecilia Giunta; Birgit Krabichler; Franz Rüschendorf; Nicoletta Zoppi; Marina Colombi; Reginald E Bittner; Susana Quijano-Roy; Francesco Muntoni; Sebahattin Cirak; Gudrun Schreiber; Yaqun Zou; Ying Hu; Norma Beatriz Romero; Robert Yves Carlier; Albert Amberger; Andrea Deutschmann; Volker Straub; Marianne Rohrbach; Beat Steinmann; Kevin Rostásy; Daniela Karall; Carsten G Bönnemann; Johannes Zschocke; Christine Fauth
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

2.  Posttranslational enzymes in the biosynthesis of collagen: intracellular enzymes.

Authors:  K I Kivirikko; R Myllylä
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

3.  FKBP14-related Ehlers-Danlos syndrome: expansion of the phenotype to include vascular complications.

Authors:  Mitzi L Murray; Margaret Yang; Christine Fauth; Peter H Byers
Journal:  Am J Med Genet A       Date:  2014-03-26       Impact factor: 2.802

Review 4.  Ehlers-Danlos syndrome related to FKBP14 mutations: detailed cutaneous phenotype.

Authors:  A C Bursztejn; M Baumann; D Lipsker
Journal:  Clin Exp Dermatol       Date:  2016-11-30       Impact factor: 3.470

5.  FKBP14 kyphoscoliotic Ehlers-Danlos Syndrome in adolescent patient: the first Colombian report.

Authors:  Felipe Ruiz-Botero; Diana Ramírez-Montaño; Harry Pachajoa
Journal:  Arch Argent Pediatr       Date:  2019-06-01       Impact factor: 0.635

6.  Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation.

Authors:  Marianne Rohrbach; Anthony Vandersteen; Uluç Yiş; Gul Serdaroglu; Esra Ataman; Maya Chopra; Sixto Garcia; Kristi Jones; Ariana Kariminejad; Marius Kraenzlin; Carlo Marcelis; Matthias Baumgartner; Cecilia Giunta
Journal:  Orphanet J Rare Dis       Date:  2011-06-23       Impact factor: 4.123

7.  A cohort of 17 patients with kyphoscoliotic Ehlers-Danlos syndrome caused by biallelic mutations in FKBP14: expansion of the clinical and mutational spectrum and description of the natural history.

Authors:  Cecilia Giunta; Matthias Baumann; Christine Fauth; Uschi Lindert; Ebtesam M Abdalla; Angela F Brady; James Collins; Jahannaz Dastgir; Sandra Donkervoort; Neeti Ghali; Diana S Johnson; Ariana Kariminejad; Johannes Koch; Marius Kraenzlin; Nayana Lahiri; Bernarda Lozic; Adnan Y Manzur; Jenny E V Morton; Jacek Pilch; Rebecca C Pollitt; Gudrun Schreiber; Nora L Shannon; Glenda Sobey; Anthony Vandersteen; Fleur S van Dijk; Martina Witsch-Baumgartner; Johannes Zschocke; F Michael Pope; Carsten G Bönnemann; Marianne Rohrbach
Journal:  Genet Med       Date:  2017-06-15       Impact factor: 8.822

8.  Transcriptome Profiling of Primary Skin Fibroblasts Reveal Distinct Molecular Features Between PLOD1- and FKBP14-Kyphoscoliotic Ehlers-Danlos Syndrome.

Authors:  Pei Jin Lim; Uschi Lindert; Lennart Opitz; Ingrid Hausser; Marianne Rohrbach; Cecilia Giunta
Journal:  Genes (Basel)       Date:  2019-07-08       Impact factor: 4.096

Review 9.  Ehlers-Danlos syndrome type IV.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2007-07-19       Impact factor: 4.123

10.  The novel missense mutation Met48Lys in FKBP22 changes its structure and functions.

Authors:  Yoshihiro Ishikawa; Nobuyo Mizuno; Paul Holden; Pei Jin Lim; Douglas B Gould; Marianne Rohrbach; Cecilia Giunta; Hans Peter Bächinger
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

View more
  1 in total

1.  Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients.

Authors:  Mihaiela L Dragoș; Iuliu C Ivanov; Mihaela Mențel; Irina C Văcărean-Trandafir; Adriana Sireteanu; Amalia A Titianu; Angela S Dăscălescu; Alexandru B Stache; Daniela Jitaru; Dragoș L Gorgan
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.